Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hui Xuan, Masomian, Malihe, Khalid, Kanwal, Kumar, Asqwin Uthaya, MacAry, Paul A., Poh, Chit Laa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/
https://www.ncbi.nlm.nih.gov/pubmed/35457159
http://dx.doi.org/10.3390/ijms23084341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/
https://www.ncbi.nlm.nih.gov/pubmed/35457159
http://dx.doi.org/10.3390/ijms23084341

Ejemplares similares